Sign inJoin waitlistJoin the waitlist

Andrew Lassman

Vice Dean for · New York Presbyterian Hospital

Credentials: · · · · ·

History

Neuro-Oncology Division · New York Presbyterian Hospital
Present
Clinical Translational Research Unit and Co-Director of the Clinical Trials Program · New York Presbyterian Hospital
Present
Clinical Research Compliance at the Columbia University Vagelos College of Physicians & Surgeons · New York Presbyterian Hospital
Present

Memorial Sloan Kettering Cancer Center
2002–2003
Neurology
New York Presbyterian Hospital
1998–2001
Neurology
Icahn School of Medicine at Mount Sinai
1997–1998
Columbia Univ Coll of Phys & Surgeons
1993–1997

Research

Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
Journal of Clinical Oncology · 2010 · 3,116 citations
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
Review · Neuro-Oncology · 2020 · 995 citations
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2022 · 714 citations

PW
Patrick Wen
40 papers
LD
Lisa DeAngelis
33 papers
Timothy Cloughesy
33 papers
LA
Lauren Abrey
29 papers
Minesh Mehta
23 papers
FI
Fabio Iwamoto
22 papers · 6 as a resident
Susan Chang
22 papers
David Schiff
20 papers
Jeffrey Bruce
18 papers
Tony Wang
17 papers · 1 as a fellow
David Reardon
16 papers
John de Groot
14 papers

Grants

Clinical Trials Specialist in NCI Clinical Trials Research
National Cancer Institute · R50
Contact PI · $387.9K · Columbia University Health Sciences
2025–2030
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $3.4M · Columbia University Health Sciences
1997–2030
Columbia University NCI Community Oncology Research Program
National Cancer Institute · UG1
PI · $7.6M · Columbia University Health Sciences
2014–2025

Clinical trials

Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
Principal investigator · Completed · Phase 2, Phase 3
National Cancer Institute (NCI)
2020–2025
A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma
Principal investigator · Terminated · Phase 1, Phase 2
Karyopharm Therapeutics Inc
2020–2023
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Principal investigator · Completed · Phase 1
Andrew B Lassman, MD
2014–2021
EGFR Inhibition Using Weekly Erlotinib for Recurrent Malignant Gliomas
Principal investigator · Completed · Phase 1
Andrew B Lassman, MD
2011–2018